|
1
|
Di Nisio M, van Es N and Büller HR: Deep
vein thrombosis and pulmonary embolism. Lancet. 388:3060–3073.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mulder FI, Horváth-Puhó E, van Es N, van
Laarhoven HWM, Pedersen L, Moik F, Ay C, Büller HR and Sørensen HT:
Venous thromboembolism in cancer patients: A population-based
cohort study. Blood. 137:1959–1969. 2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Khorana AA, Mackman N, Falanga A, Pabinger
I, Noble S, Ageno W, Moik F and Lee AYY: Cancer-associated venous
thromboembolism. Nat Rev Dis Primers. 8(11)2022.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Falanga A, Russo L, Milesi V and Vignoli
A: Mechanisms and risk factors of thrombosis in cancer. Crit Rev
Oncol Hematol. 118:79–83. 2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Mahajan A, Brunson A, White R and Wun T:
The epidemiology of cancer-associated venous thromboembolism: An
update. Semin Thromb Hemost. 45:321–325. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Fernandes CJ, Morinaga LTK, Alves JLJ,
Castro MA, Calderaro D, Jardim CVP and Souza R: Cancer-associated
thrombosis: The when, how and why. Eur Respir Rev.
28(180119)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Weitz JI, Haas S, Ageno W, Goldhaber SZ,
Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat
AE, et al: Cancer associated thrombosis in everyday practice:
Perspectives from GARFIELD-VTE. J Thromb Thrombolysis. 50:267–277.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Levitan N, Dowlati A, Remick SC, Tahsildar
HI, Sivinski LD, Beyth R and Rimm AA: Rates of initial and
recurrent thromboembolic disease among patients with malignancy
versus those without malignancy. Risk analysis using Medicare
claims data. Medicine (Baltimore). 78:285–291. 1999.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Kenmotsu H, Notsu A, Mori K, Omori S,
Tsushima T, Satake Y, Miki Y, Abe M, Ogiku M, Nakamura T, et al:
Cumulative incidence of venous thromboembolism in patients with
advanced cancer in prospective observational study. Cancer Med.
10:895–904. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ohashi Y, Ikeda M, Kunitoh H, Sasako M,
Okusaka T, Mukai H, Fujiwara K, Nakamura M, Oba MS, Kimura T, et
al: Venous thromboembolism in cancer patients: Report of baseline
data from the multicentre, prospective cancer-VTE registry. Jpn J
Clin Oncol. 50:1246–1253. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Peng M, Yang S, Li G, Zhang T, Qin X, Shi
C, Chang J, Chen M, Chen C, Li B, et al: Solid tumor complicated
with venous thromboembolism: A 10-year retrospective
cross-sectional study. Clin Appl Thromb Hemost.
27(1076029620975484)2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bao Y, Wan X, Fu J and Wu B: The risk of
venous thromboembolism in cancer patients receiving chemotherapy: A
meta-analysis with systematic review. Ann Transl Med.
9(277)2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Cohen AT, Katholing A, Rietbrock S, Bamber
L and Martinez C: Epidemiology of first and recurrent venous
thromboembolism in patients with active cancer. A population-based
cohort study. Thromb Haemost. 117:57–65. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gurizzan C, Roca E, Faggiano A, Paoli D,
Dinatolo E, Masini G, Tomasi C, De Palma G, Metra M, Berruti A and
Faggiano P: Rate of venous thromboembolism and atrial fibrillation
in a real-world case series of advanced cancer patients: The CaTEV
study. J Cardiovasc Med (Hagerstown). 22:444–452. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Key NS, Khorana AA, Kuderer NM, Bohlke K,
Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW,
et al: Venous thromboembolism prophylaxis and treatment in patients
with cancer: ASCO clinical practice guideline update. J Clin Oncol.
38:496–520. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Centers for Disease Control and
Prevention: ICD-10-CM Browser Tool. https://www.cdc.gov/nchs/icd/icd10cm_browsertool.htm.
Accessed November 20, 2019.
|
|
17
|
Piñeros M, Parkin DM, Ward K, Chokunonga
E, Ervik M, Farrugia H, Gospodarowicz M, O'Sullivan B,
Soerjomataram I, Swaminathan R, et al: Essential TNM: A registry
tool to reduce gaps in cancer staging information. Lancet Oncol.
20:e103–e111. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Khorana AA, Francis CW, Culakova E,
Kuderer NM and Lyman GH: Frequency, risk factors, and trends for
venous thromboembolism among hospitalized cancer patients. Cancer.
110:2339–2346. 2007.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Abdol Razak NB, Jones G, Bhandari M,
Berndt MC and Metharom P: Cancer-associated thrombosis: An overview
of mechanisms, risk factors, and treatment. Cancers (Basel).
10(380)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sakamoto J, Yamashita Y, Morimoto T, Amano
H, Takase T, Hiramori S, Kim K, Oi M, Akao M, Kobayashi Y, et al:
Cancer-associated venous thromboembolism in the real world-from the
COMMAND VTE registry. Circ J. 83:2271–2281. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Arachchillage DR and Laffan M:
Pathogenesis and management of thrombotic disease in
myeloproliferative neoplasms. Semin Thromb Hemost. 45:604–611.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ahlbrecht J, Dickmann B, Ay C, Dunkler D,
Thaler J, Schmidinger M, Quehenberger P, Haitel A, Zielinski C and
Pabinger I: Tumor grade is associated with venous thromboembolism
in patients with cancer: Results from the Vienna cancer and
thrombosis study. J Clin Oncol. 30:3870–3875. 2012.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rondon AMR, Kroone C, Kapteijn MY,
Versteeg HH and Buijs JT: Role of tissue factor in tumor
progression and cancer-associated thrombosis. Semin Thromb Hemost.
45:396–412. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Donnellan E and Khorana AA: Cancer and
venous thromboembolic disease: A review. Oncologist. 22:199–207.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Frere C: Burden of venous thromboembolism
in patients with pancreatic cancer. World J Gastroenterol.
27:2325–2340. 2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Khorana AA, Dalal M, Lin J and Connolly
GC: Incidence and predictors of venous thromboembolism (VTE) among
ambulatory high-risk cancer patients undergoing chemotherapy in the
United States. Cancer. 119:648–655. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Ma SQ, Lin Y, Ying HY, Shao YJ, Li XY and
Bai CM: Solid malignancies complicated with pulmonary embolism:
clinical analysis of 120 patients. Chin Med J (Engl). 123:29–33.
2010.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Huisman MV, Barco S, Cannegieter SC, Le
Gal G, Konstantinides SV, Reitsma PH, Rodger M, Vonk Noordegraaf A
and Klok FA: Pulmonary embolism. Nat Rev Dis Primers.
4(18028)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Robert-Ebadi H and Righini M: Management
of distal deep vein thrombosis. Thromb Res. 149:48–55.
2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Caldwell K, Prior SJ, Kampmann M, Zhao L,
McEvoy S, Goldberg AP and Lal BK: . Upper body exercise increases
lower extremity venous blood flow in deep venous thrombosis. J Vasc
Surg Venous Lymphat Disord. 1:126–133. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shimizu Y, Kamada H, Sakane M, Aikawa S,
Mutsuzaki H, Tanaka K, Mishima H, Ochiai N and Yamazaki M: A novel
apparatus for active leg exercise improves venous flow in the lower
extremity. J Sports Med Phys Fitness. 56:1592–1597. 2016.PubMed/NCBI
|
|
32
|
Shalhoub J, Lawton R, Hudson J, Baker C,
Bradbury A, Dhillon K, Everington T, Gohel MS, Hamady Z, Hunt BJ,
et al: Compression stockings in addition to low-molecular-weight
heparin to prevent venous thromboembolism in surgical inpatients
requiring pharmacoprophylaxis: the GAPS non-inferiority RCT. Health
Technol Assess. 24:1–80. 2020.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Suzuki T, Fujino S, Inaba S, Yamamura R,
Katoh H, Noji Y, Yamaguchi M and Aoyama T: Venous thromboembolism
in patents with lung cancer. Clin Appl Thromb Hemost.
26(1076029620977910)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Streiff MB, Holmstrom B, Angelini D,
Ashrani A, Bockenstedt PL, Chesney C, Fanikos J, Fenninger RB,
Fogerty AE, Gao S, et al: NCCN guidelines insights:
cancer-associated venous thromboembolic disease, version 2.2018. J
Natl Compr Canc Netw. 16:1289–1303. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fuentes HE, McBane RD II, Wysokinski WE,
Tafur AJ, Loprinzi CL, Murad MH and Riaz IB: Direct oral factor Xa
inhibitors for the treatment of acute cancer-associated venous
thromboembolism: A systematic review and network meta-analysis.
Mayo Clin Proc. 94:2444–2454. 2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ay C, Beyer-Westendorf J and Pabinger I:
Treatment of cancer-associated venous thromboembolism in the age of
direct oral anticoagulants. Ann Oncol. 30:897–907. 2019.PubMed/NCBI View Article : Google Scholar
|
